TREVICTA PALIPERIDONE 525MG INJECTION

Trevicta (generic name: paliperidone palmitate) is an injectable antipsychotic medication primarily used for the treatment of schizophrenia in adults. It is a long-acting formulation of paliperidone, which is an active metabolite of risperidone. Trevicta is administered as an intramuscular injection, typically once every three months, making it a convenient option for patients who may have difficulty adhering to daily oral medication regimens.

The drug works by modulating the effects of neurotransmitters in the brain, particularly dopamine and serotonin, which are believed to play a key role in the symptoms of schizophrenia. Trevicta helps to reduce the risk of relapse in patients with schizophrenia and can improve overall functioning and quality of life. It is important for patients to be monitored for side effects, which can include weight gain, metabolic changes, and extrapyramidal symptoms.